{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:36:56Z","timestamp":1776803816550,"version":"3.51.2"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s179208","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T21:02:14Z","timestamp":1551214934000},"page":"343-354","source":"Crossref","is-referenced-by-count":6,"title":["&lt;p&gt;Treatment with &lt;em&gt;Saccharomyces boulardii&lt;\/em&gt; and &lt;em&gt;Escherichia coli&lt;\/em&gt; Nissle is safe and associated with reduced nosocomial transmission of &lt;em&gt;van&lt;\/em&gt;B vancomycin-resistant &lt;em&gt;Enterococcus faecium&lt;\/em&gt; on an early rehabilitation ward in Germany: a retrospective analysis&lt;\/p&gt;"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Stefan","family":"Borgmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Rie\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabea","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Klare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,2]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=48310","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=48310","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T21:02:15Z","timestamp":1551214935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/treatment-with-saccharomyces-boulardii-and-escherichia-coli-nissle-is--peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s179208","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}